Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Quantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitor.

Han B, Wright R, Kirchhoff AM, Chester JA, Cooper BR, Davisson VJ, Barker E.

Anal Biochem. 2013 Jan 15;432(2):74-81. doi: 10.1016/j.ab.2012.09.031. Epub 2012 Oct 5.

2.

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.

Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM.

BMC Biochem. 2009 May 21;10:14. doi: 10.1186/1471-2091-10-14.

3.

Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure.

Carr RL, Adams AL, Kepler DR, Ward AB, Ross MK.

Toxicol Sci. 2013 Sep;135(1):193-201. doi: 10.1093/toxsci/kft126. Epub 2013 Jun 12.

4.

A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids.

Qi M, Morena M, Vecchiarelli HA, Hill MN, Schriemer DC.

Rapid Commun Mass Spectrom. 2015 Oct 30;29(20):1889-97. doi: 10.1002/rcm.7277.

PMID:
26411510
5.

Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.

Gouveia-Figueira S, Karlsson J, Deplano A, Hashemian S, Svensson M, Fredriksson Sundbom M, Congiu C, Onnis V, Fowler CJ.

PLoS One. 2015 Sep 25;10(9):e0139212. doi: 10.1371/journal.pone.0139212. eCollection 2015.

6.

Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.

Karlsson J, Gouveia-Figueira S, Alhouayek M, Fowler CJ.

PLoS One. 2017 Sep 14;12(9):e0185011. doi: 10.1371/journal.pone.0185011. eCollection 2017.

7.

CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.

Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.

Eur J Neurosci. 2007 Dec;26(12):3458-64. Epub 2007 Dec 4.

PMID:
18052990
8.

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.

J Pharmacol Exp Ther. 2005 Apr;313(1):352-8. Epub 2004 Dec 3.

9.

Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.

Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G, Maccarrone M.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2997-3004.

PMID:
17591864
10.

Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.

Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA.

Anal Biochem. 2007 Jan 15;360(2):216-26. Epub 2006 Nov 13.

PMID:
17141174
11.

A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase.

Grazia Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V.

Biochem Biophys Res Commun. 2004 Jan 30;314(1):192-6.

PMID:
14715265
12.

Simultaneous HPLC-APCI-MS/MS quantification of endogenous cannabinoids and glucocorticoids in hair.

Mwanza C, Chen Z, Zhang Q, Chen S, Wang W, Deng H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:1-10. doi: 10.1016/j.jchromb.2016.06.002. Epub 2016 Jun 2.

PMID:
27318292
13.
14.

Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.

Smaga I, Bystrowska B, Gawliński D, Pomierny B, Stankowicz P, Filip M.

Neurotox Res. 2014 Aug;26(2):190-206. doi: 10.1007/s12640-014-9465-0. Epub 2014 Mar 21.

15.

Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.

Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.

Oncotarget. 2016 Mar 22;7(12):15047-64. doi: 10.18632/oncotarget.7592.

16.

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.

PLoS One. 2013;8(4):e60040. doi: 10.1371/journal.pone.0060040. Epub 2013 Apr 3.

17.

The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.

Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.

J Pharmacol Exp Ther. 2007 Apr;321(1):370-80. Epub 2007 Jan 8.

18.

Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.

Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A.

Anal Chem. 2007 Aug 1;79(15):5582-93. Epub 2007 Jun 29.

PMID:
17600384
19.

Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.

Lau BK, Drew GM, Mitchell VA, Vaughan CW.

Br J Pharmacol. 2014 Dec;171(23):5225-36. doi: 10.1111/bph.12839. Epub 2014 Sep 5.

20.

Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.

Siegmund SV, Wojtalla A, Schlosser M, Zimmer A, Singer MV.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):48-54. doi: 10.1016/j.bbrc.2013.06.033. Epub 2013 Jun 24.

PMID:
23806692

Supplemental Content

Support Center